ABC3 Consensus: Assessment by a German Group of Experts

Por Thomssen, Christoph, Augustin, Doris, Ettl, Johannes, Haidinger, Renate, Lück, Hans-Joachim, Lüftner, Diana, Marmé, Frederik, Marschner, Norbert, Müller, Lothar, Overkamp, Friedrich, Ruckhäberle, Eugen, Thill, Marc, Untch, Michael, Wuerstlein, Rachel, Harbeck, Nadia
Publicado no Breast Care (Basel) (2016)

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docet...

Por Kantelhardt, Eva J, Vetter, Martina, Schmidt, Marcus, Veyret, Corinne, Augustin, Doris, Hanf, Volker, Meisner, Christoph, Paepke, Daniela, Schmitt, Manfred, Sweep, Fred, von Minckwitz, Gunter, Martin, Pierre-Marie, Jaenicke, Fritz, Thomssen, Christoph, Harbeck, Nadia
Publicado em 2011

Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

Por Schönherr, Alexandra, Aivazova-Fuchs, Viktoria, Annecke, Katja, Jückstock, Julia, Hepp, Philip, Andergassen, Ulrich, Augustin, Doris, Simon, Wolfgang, Wischnik, Arthur, Mohrmann, Svjetlana, Salmen, Jessica, Zwingers, Thomas, Kiechle, Marion, Harbeck, Nadja, Friese, Klaus, Janni, Wolfgang, Rack, Brigitte
Publicado em 2012

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study

Por Harbeck, Nadia, Saupe, Steffen, Jäger, Elke, Schmidt, Marcus, Kreienberg, Rolf, Müller, Lothar, Otremba, Burkhard Joerg, Waldenmaier, Dirk, Dorn, Julia, Warm, Mathias, Scholz, Michael, Untch, Michael, de Wit, Maike, Barinoff, Jana, Lück, Hans-Joachim, Harter, Philipp, Augustin, Doris, Harnett, Paul, Beckmann, Matthias W., Al-Batran, Salah-Eddin
Publicado no Breast Cancer Res Treat (2016)